Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers discovered a key process where malarial parasites take up a human blood cell ...

Malaria is a constant threat for nearly half of the world’s population, and people who travel to those areas are also at risk. Although the short-term side effects of prophylactic drugs are ...

GENEVA (AP) — Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as an advance against a disease that takes hundreds of ...

LONDON (Reuters) -A new antimalarial drug developed by Novartis is as effective as existing treatments and could help tackle rising drug resistance, the company said on Wednesday as it presented final ...

Dr. Reddy’s and its CRDMO arm Aurigene Pharmaceutical Services have signed a non-binding Memorandum of Understanding with Kainomyx, a U.S.-based company with a platform that helps target cytoskeletal ...

Malaria represents one of the most serious threats to human health worldwide, and preventing and curing this parasitic disease still depends predominantly on the administration of a small number of ...

Researchers at University of California San Diego analyzed the genomes of hundreds of malaria parasites to determine which genetic variants are most likely to confer drug resistance. The findings, ...

While celebrating Youyou Tu’s achievements in antimalarial therapy and her receipt of the 2015 Nobel Prize in Physiology or Medicine (C&EN, Oct. 12, page 7), it’s worthwhile to note that the discovery ...

The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers. In these diseases, a mutation in the genetic code ...

Cardiac fibrosis is a frequent comorbidity in many diseases, such as ischemic heart failure or diabetes mellitus, contributing to increased mortality. No drugs are approved for cardiac fibrosis and ...

Up to now, antimalarial drugs designed for older children have been administered to small infants in careful ways to avoid overdose or toxicity, in what Bassat called a “suboptimal solution” that the ...